New Treatment for IDH mt Gliomas
Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas.
Read the related article in The New England Journal of Medicine.
Visit NPUb.org/Podcast for associated article links.
You May Also Like
The Rainbow Path Society
Dr.John Allen Reilly and Pr.Cristoforo Padula
Daily Motivations
Tolulope Akodu
Erotic Stories
Sexuality and Erotica
Erotic Short Stories: Read by Mia Hart
Sexuality and Erotica
Your Daily Dose
Dr Len Brancewicz, RPh, NMD
The Healthy Diabetic
Coach Ken Kniss
Rain Sounds
Rain Sounds
Navigating Ozempic-#Ozempic
Liquid Studios
Strictly Anonymous Confessions
Kathy Kay
Thunderstorm Ambience
Sol Good Media
The Rainbow Path Society
Dr.John Allen Reilly and Pr.Cristoforo Padula
Daily Motivations
Tolulope Akodu
Erotic Stories
Sexuality and Erotica
Erotic Short Stories: Read by Mia Hart
Sexuality and Erotica
Your Daily Dose
Dr Len Brancewicz, RPh, NMD
The Healthy Diabetic
Coach Ken Kniss
Rain Sounds
Rain Sounds
Navigating Ozempic-#Ozempic
Liquid Studios
Strictly Anonymous Confessions
Kathy Kay
Thunderstorm Ambience
Sol Good Media
Community discussion